カテゴリ： GlobalData, アメリカ, 企業調査

WellCare Health Plans Inc (WCG)-製薬・医療分野：企業M&A・提携分析

◆英語タイトル：WellCare Health Plans Inc (WCG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8013457
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月28日
◆ページ数：100
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
WellCare Health Plans Inc (WellCare) is a managed care service provider which focuses on providing government-sponsored managed care services to families, children, seniors and individuals with complex medical needs. The company offers Medicaid health plans, Medicare Advantage (MA) coordinated care plans (CCPs), and stand-alone Medicare prescription drug plans (PDP). Its Medicaid health plans include plans for beneficiaries of TANF (Temporary Assistance for Needy Families), SSI (Supplemental Security Income) and ABD (Aged, Blind and Disabled) programs and other state based programs. WellCare contracts with Centers for Medicare and Medicaid Services to provide its services. The company offers its services to customers in various states in the US; and the District of Columbia. WellCare is headquartered in Tampa, Florida, the US.

WellCare Health Plans Inc (WCG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 6
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
WellCare Health Plans Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
WellCare Health Completes Acquisition Of Medicaid Business Of UnitedHealth 11
Debt Offering 13
WellCare Health Raises USD300 Million in Public Offering of 5.75% Notes Due 2020 13
WellCare Health Completes Public Offering Of Notes Due 2020 For US$600 Million 15
Acquisition 17
WellCare Health Completes Acquisition Of Missouri Care, Managed Care Services Provider 17
WellCare Health Completes Acquisition Of Easy Choice Health Plan, Healthcare Services Provider 18
WellCare Health Plans Inc – Key Competitors 19
WellCare Health Plans Inc – Key Employees 20
WellCare Health Plans Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Financial Announcements 24
Oct 31, 2017: WellCare Reports Third Quarter 2017 Results 24
Aug 04, 2017: WellCare Reports Second Quarter 2017 Results 27
May 03, 2017: WellCare Reports First Quarter 2017 Results 30
Feb 07, 2017: WellCare Reports Fourth Quarter And Full-Year 2016 Results 31
Nov 01, 2016: WellCare Reports Third Quarter 2016 Results 33
Aug 02, 2016: WellCare Reports Second Quarter 2016 Results 35
May 03, 2016: WellCare Reports First Quarter 2016 Results 37
Feb 09, 2016: WellCare Reports Fourth Quarter And Full-Year 2015 Results 39
Corporate Communications 41
Jul 11, 2017: WellCare Names Dr. Mark Leenay Chief Medical Officer 41
Apr 11, 2017: WellCare Names Scott Sivik State President, ‘Ohana Health Plan 42
Jan 18, 2017: WellCare Names W. Lee Bowers COO, Florida 43
Jan 12, 2017: WellCare Names Marla Purvis COO, Georgia 44
Jan 09, 2017: WellCare Names Timothy Trodden Chief Human Resources Officer 45
Sep 29, 2016: WellCare Appoints H. James Dallas to Board of Directors 46
Aug 29, 2016: WellCare Names Dr. Mark Leenay Chief Medical Director 47
Aug 19, 2016: WellCare Gives $10,000 to the American Red Cross to Support Flood Relief Efforts in Louisiana 48
Jul 22, 2016: WellCare Names Ryan Randall COO, Georgia 49
Jun 27, 2016: WellCare Names Karen M. Johnson COO, California 50
Apr 18, 2016: WellCare Names Darren Ghanayem Chief Information Officer 51
Apr 18, 2016: WellCare Names Rubel State President, Nebraska 52
Mar 24, 2016: WellCare Increases Suicide Prevention Efforts in the Workplace in Kentucky 53
Mar 16, 2016: WellCare Donates $50,000 to the Memorial Health Foundation to Help Children with Type 1 Diabetes in Georgia and South Carolina 54
Mar 10, 2016: WellCare Gives $3,000 to Improve Literacy for Low-Income Families in Georgia 55
Feb 25, 2016: WellCare Gives $15,000 to Encourage Medical Students to Practice in Georgia’s Rural Communities 56
Feb 19, 2016: WellCare Associates Race to Raise Awareness of Homelessness In South Carolina 57
Feb 12, 2016: WellCare Honors Elizabeth, New Jersey Director of Health and Human Services with CommUnity Hero Award 58
Jan 16, 2016: WellCare Gives $5,000 to Juvenile Diabetes Research Foundation to Support Efforts to Find a Cure and New Treatments 59
Legal and Regulatory 60
Feb 06, 2017: WellCare Receives NCQA Quality Accreditation for Medicaid and Medicare Health Plans in Illinois 60
Jan 25, 2017: WellCare Receives NCQA Quality Accreditation for Medicaid and Medicare Health Plans in New York 61
Oct 06, 2016: WellCare Receives NCQA Quality Accreditation for Medicaid Health Plan in Kentucky 62
Sep 08, 2016: WellCare Receives NCQA Quality Accreditation for Its Medicare Advantage Health Plan in Texas 63
Aug 18, 2016: WellCare Receives NCQA Quality Accreditation for Its Medicare Advantage Health Plans in Arkansas, Mississippi and Tennessee 64
Aug 16, 2016: WellCare Receives NCQA Quality Accreditation for Its Medicare Advantage Health Plan in South Carolina 65
Jul 21, 2016: WellCare Receives NCQA Quality Accreditation for Its Medicare Advantage Health Plan in Connecticut 66
Apr 13, 2016: WellCare Receives NCQA Quality Accreditation for Medicaid and Medicare Health Plans in Florida 67
Feb 11, 2016: WellCare’s Exactus Pharmacy Solutions Achieves URAC Specialty Pharmacy Accreditation 68
Government and Public Interest 69
Oct 25, 2017: WellCare Pharmacy Management Pilot Program Reduces Opioid Dispensing by 50 Percent Among At-Risk Populations 69
Oct 19, 2016: WellCare to Award $25,000 in Micro-Grants to Support Social Service Agencies in Kentucky 70
Aug 30, 2016: WellCare Gives $5,000 in Micro-Grants to Community-Based Organizations in Nevada 71
Aug 24, 2016: WellCare of Kentucky Gives Micro-Grants to Community-Based Organizations that Provide Pregnancy-Related Support Services 72
Feb 22, 2016: WellCare Gives $15,000 in Micro-Grants to Community-Based Organizations that Support Social Services in Missouri 73
Other Significant Developments 74
Nov 16, 2017: Missouri Care’s Mobile App Offers Convenient Healthcare Information for Medicaid Members 74
Mar 28, 2017: WellCare Offers Comprehensive Dental Benefits to Its Adult Medicaid Members in Georgia 75
Dec 01, 2016: Staywell Health Plan Rewards Behavioral Health Providers for Prioritizing Treatment for Mental Illness 76
Oct 27, 2016: WellCare to Pilot In-Home Telemonitoring Program in Arkansas, Mississippi and Tennessee 77
Oct 26, 2016: WellCare of Kentucky Offers Expanded Benefits for Its Medicaid Members 78
Oct 25, 2016: WellCare of New York Offers 2017 Medicare Advantage Options to Help Seniors Achieve and Maintain Optimal Health 79
Oct 19, 2016: WellCare of New York Expands Field-Based Care Management Program to Deliver Personalized Care for High-Risk Members 80
Oct 18, 2016: WellCare Receives Notice of Award to Serve MO HealthNet Managed Care (Medicaid) Program Statewide 81
Oct 17, 2016: WellCare Expands 2017 Medicare Advantage Plan Options in Illinois 82
Oct 17, 2016: WellCare of Texas Offers 2017 Medicare Advantage Options to Help Seniors Achieve and Maintain Optimal Health 83
Oct 17, 2016: WellCare of South Carolina Offers 2017 Medicare Advantage Options That Promote Preventive and Maintenance Care 84
Oct 17, 2016: WellCare of Kentucky Offers 2017 Medicare Advantage Options That Promote Preventive and Maintenance Care 85
Oct 17, 2016: WellCare Offers Mississippi Seniors 2017 Medicare Advantage Options That Promote Preventive and Maintenance Care 86
Oct 17, 2016: WellCare of Connecticut Offers 2017 Medicare Advantage Options to Help Seniors Achieve and Maintain Optimal Health 87
Oct 17, 2016: WellCare Offers Arkansas Seniors 2017 Medicare Advantage Options That Promote Preventive and Maintenance Care 88
Oct 17, 2016: WellCare of Louisiana Offers 2017 Medicare Advantage Options to Help Seniors Achieve and Maintain Optimal Health 89
Oct 17, 2016: WellCare of Georgia Offers 2017 Medicare Advantage Options That Promote Preventive and Maintenance Care 90
Oct 17, 2016: WellCare Offers Tennessee 2017 Medicare Advantage Options That Promote Preventive and Maintenance Care 91
Oct 17, 2016: WellCare of Florida Offers 2017 Medicare Advantage Options To Help Seniors Achieve and Maintain Optimal Health 92
Jun 23, 2016: WellCare Expands Medicaid Benefits in Georgia to Promote Preventive Care 93
Jun 13, 2016: WellCare of New York Increasingly Moves to Value-Based Reimbursement Agreements to Align Provider Payments with Health Outcomes 94
Apr 07, 2016: New York’s Office of Health Insurance Programs Ranks WellCare’s Managed Long-Term Care Plan Among State’s Best 95
Mar 29, 2016: WellCare’s Staywell Health Plan Offers Behavioral Health Care via Telehealth to Increase Access, Convenience and Engagement for Its Florida Medicaid Members 96
Mar 08, 2016: WellCare Launches Fully-Integrated Clinical Platform to Improve Member Outcomes and Drive Efficiencies 97
Feb 18, 2016: WellCare Expands Field-Based Care Management Program to Deliver Cost Efficient and Personalized Care for High-Risk Members 98
Feb 10, 2016: Staywell Health Plan’s Care Model Delivers Personalized Care for High-Risk Members 99
Appendix 100
Methodology 100
About GlobalData 100
Contact Us 100
Disclaimer 100

List of Tables
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
WellCare Health Plans Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
WellCare Health Plans Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
WellCare Health Completes Acquisition Of Medicaid Business Of UnitedHealth 11
WellCare Health Raises USD300 Million in Public Offering of 5.75% Notes Due 2020 13
WellCare Health Completes Public Offering Of Notes Due 2020 For US$600 Million 15
WellCare Health Completes Acquisition Of Missouri Care, Managed Care Services Provider 17
WellCare Health Completes Acquisition Of Easy Choice Health Plan, Healthcare Services Provider 18
WellCare Health Plans Inc, Key Competitors 19
WellCare Health Plans Inc, Key Employees 20
WellCare Health Plans Inc, Subsidiaries 22

★海外企業調査レポート[WellCare Health Plans Inc (WCG)-製薬・医療分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • ONGC Videsh Ltd：企業のM&A・事業提携・投資動向
    ONGC Videsh Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ONGC Videsh Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Emera Inc (EMA)：電力：M&Aディール及び事業提携情報
    Summary Emera Inc (Emera) is an energy and services company. It invests in electricity, natural gas and utility energy services. Through ownership and equity investments in various companies, Emera generates, transmits and distributes electricity; procures, transmits and distributes natural gas; mar …
  • Swedbank AB：企業の戦略・SWOT・財務分析
    Swedbank AB - Strategy, SWOT and Corporate Finance Report Summary Swedbank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Alcon Laboratories Inc：医療機器：M&Aディール及び事業提携情報
    Summary Alcon Laboratories Inc (Alcon), a division of Novartis AG, develops and manufactures devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products. Alcon’s products are used for the treatment of various conditions such as cataracts, glaucoma, …
  • Finmeccanica SpA：戦略・SWOT・企業財務分析
    Finmeccanica SpA - Strategy, SWOT and Corporate Finance Report Summary Finmeccanica SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ERG Renew SpA-エネルギー分野：企業M&A・提携分析
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Assembly Biosciences Inc (ASMB)-製薬・医療分野：企業M&A・提携分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that discover, develops and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as chronic hepatitis B virus (HBV) and microbioti …
  • Aegion Corp (AEGN)：企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Gaia, Inc. (GAIA)：企業の財務・戦略的SWOT分析
    Gaia, Inc. (GAIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tenaris SA：戦略・SWOT・企業財務分析
    Tenaris SA - Strategy, SWOT and Corporate Finance Report Summary Tenaris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • NiSource Inc.：企業の戦略・SWOT・財務分析
    NiSource Inc. - Strategy, SWOT and Corporate Finance Report Summary NiSource Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • F. Hoffmann-La Roche Ltd (ROG)：医療機器：M&Aディール及び事業提携情報
    Summary F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company, which develops drugs and diagnostics that improve the standard of care in major disease areas. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, hematology, ne …
  • Cyalume Technologies Holdings, Inc.：企業の戦略・SWOT・財務情報
    Cyalume Technologies Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cyalume Technologies Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Midatech Pharma US Inc：医療機器：M&Aディール及び事業提携情報
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. It is a subsidiary of Midatech Pharma Plc. The company’s product portfolio includes …
  • Bone Therapeutics SA (BOTHE)：製薬・医療：M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Immunicum AB (IMMU)：企業の財務・戦略的SWOT分析
    Summary Immunicum AB (Immunicum) develops allogeneic and off-the-shelf cell-based therapies for treating solid tumors. The company’s lead product candidate ilixadencel, an off the cell cancer immune primer is used for the treatment of renal cell carcinoma, gastrointestinal stromal tumors, head and n …
  • Promius Pharma LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Promius Pharma LLC (Promius Pharma), a subsidiary of Dr. Reddy's Laboratories Ltd, is a designer of personal and practical health care solutions that provides dermatology and neurology products. The company provides dermatology and neurology products. Its products include clocortolone pivala …
  • Oxford Biodynamics Plc-医療機器分野：企業M&A・提携分析
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, …
  • Arab African International Bank：企業の戦略・SWOT・財務情報
    Arab African International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab African International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Black Ridge Oil & Gas Inc (ANFC)：石油・ガス：M&Aディール及び事業提携情報
    Summary Black Ridge Oil & Gas Inc (Black Ridge), formerly Ante5 Inc is an oil and gas company that acquires, develops, explores and produces crude oil and natural gas properties. The company's projects are located in Bakken and three Forks trends in Montana and North Dakota. It acquires gas assets t …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆